Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs2600867 | chr15:48031230 | A/C | 9.67E-6 | 134 | 45.47 | 40.57 | 16.53 | KM Plot |
| TGCT | rs261375 | chr13:21871882 | A/G | 5.5E-7 | 134 | 23.43 | 36.7 | 43.68 | KM Plot |
| TGCT | rs261423 | chr13:21852331 | A/C | 6.44E-7 | 132 | 46.3 | 35.73 | 14.42 | KM Plot |
| TGCT | rs261426 | chr13:21852789 | T/C | 6.44E-7 | 132 | 46.3 | 35.73 | 14.42 | KM Plot |
| TGCT | rs2644706 | chr17:673895 | C/G | 7.43E-5 | 130 | 20.6 | 22.83 | 46.07 | KM Plot |
| TGCT | rs2740343 | chr17:669546 | A/T | 7.43E-5 | 130 | 20.6 | 22.83 | 46.07 | KM Plot |
| TGCT | rs2741502 | chr20:43936265 | C/T | 0.000121 | 134 | 42.12 | 42.1 | 38.2 | KM Plot |
| TGCT | rs2750009 | chr17:678380 | A/G | 7.43E-5 | 130 | 20.6 | 22.83 | 46.07 | KM Plot |
| TGCT | rs2750012 | chr17:684261 | G/A | 7.43E-5 | 130 | 20.6 | 22.83 | 46.07 | KM Plot |
| TGCT | rs2750013 | chr17:686133 | A/G | 6.73E-5 | 131 | 20.6 | 22.83 | 46.3 | KM Plot |
| TGCT | rs2783107 | chr13:21837532 | C/A | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs2798601 | chr1:154779685 | A/G | 7.42E-6 | 134 | 46.3 | 36.63 | 46.3 | KM Plot |
| TGCT | rs2830109 | chr21:27569389 | A/T | 2.69E-5 | 129 | 42.1 | 52.43 | 17.1 | KM Plot |
| TGCT | rs28495349 | chr8:103086081 | T/C | 0.00011 | 134 | 42.27 | 28.27 | 48.45 | KM Plot |
| TGCT | rs28538699 | chr19:37967689 | G/T | 1.76E-13 | 133 | 45.47 | 36.12 | 17.1 | KM Plot |